Introduction
============

The signal transduction cascade of depolarizing bipolar cells (DBCs) is initiated when a light-induced reduction in glutamate release from photoreceptor terminals is sensed by the metabotropic glutamate receptor 6 (mGluR6) \[[@r1],[@r2]\]. DBC activity underlies the b-wave component of the electroretinogram (ERG) \[[@r3]-[@r7]\], and the b-wave is missing in humans carrying mutations in *GRM6* (OMIM [604096](https://omim.org/entry/604096)) \[[@r8],[@r9]\], and in mouse models lacking mGluR6 due to null mutations in *Grm6* \[[@r10]-[@r13]\].

We recently reported the *Grm6^nob8^* mutant mouse model in which the ERG b-wave is reduced but is not eliminated \[[@r14]\]. The mouse carries a missense mutation, p.Met66Leu. Immunohistochemistry documented abnormal distribution of mGluR6, with a substantial fraction retained within the DBC soma and abnormally low levels of mGluR6 at the DBC dendritic tips. In the *Grm6^nob8^* model, mutant mGluR6 was abnormally glycosylated, a state that has been shown to result in abnormal trafficking of other G-protein coupled receptors \[[@r15]-[@r17]\].

In the present report, we follow up on the observation in the mouse model mentioned above in two respects. To determine whether reducing levels of mutant mGluR6 might normalize localization within *Grm6^nob8^* DBCs, we genetically reduced the amount of mGluR6 by crossing the *Grm6^nob8^* mutant with a Grm6 null model (*Grm6^nob3^*). Although we are unaware of a comparable approach, we note that mislocalized mutant proteins are associated with neuronal degeneration in other systems \[e.g., [@r18],[@r19]\]. Given the relevance of *Grm6* mutant mice to the human condition complete congenital stationary night blindness (cCSNB) \[[@r14]\] and the identification of human mutations near the *nob8* locus \[[@r20]\], we examined the retinal structure and function in *Grm6^nob8^* mice at ages up to 1 year old.

Methods
=======

Mice
----

Mice were obtained from the Jackson Laboratory (Bar Harbor, ME). The lines used were CBA/CaJ that are homozygous for the *Grm6^nob8^* allele (stock \#000654; hereafter *Grm6^nob8^*), C57BL/6J (stock \#000664), and B6.B10(D2)-*Grm6^nob3^*/BOC mice that are homozygous for a null mutation in *Grm6* \[[@r12]\]; hereafter, *Grm6^nob3^*. In addition to these homozygous lines, we crossed *Grm6^nob8^* and *Grm6^nob3^* mice to generate *Grm6^nob3/nob8^* compound heterozygotes. Mice were housed conventionally, in microisolator cages with free access to food and water. All procedures involving live animals were approved by the Cleveland Clinic Institutional Animal Care and Use Committee, and were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

Western blotting
----------------

Mouse retinas were isolated and homogenized in lysis buffer (1% Nonidet P40, 2 mM EDTA, and 20 mM HEPES, pH 7.4, supplemented with protease inhibitor cocktail (P8340, Sigma-Aldrich, St. Louis, MO), and lysed further by rotating at 4 °C for 45 min. Homogenates were cleared by centrifugation at 17,000 ×*g* for 20 min at 4 °C. Protein samples were separated with sodium dodecyl sulfate--polyacrylamide gel electrophoresis (SDS--PAGE) and transferred to polyvinylidene fluoride (PVDF) membranes, and immunoblotting was performed as described previously \[[@r21]\]. Protein bands were visualized by scanning the membranes in an Odyssey Infrared Imaging System (LI-COR, Lincoln, NE) using 700 nm and 800 nm channels. Band densities were quantified using Image Studio Version 5.0 software (LI-COR).

Immunohistochemistry
--------------------

At 4 weeks, the mice were euthanized with carbon dioxide inhalation, and the eyes were enucleated. Dissected retinas were fixed for 20 min by immersion in 4% (w/v) paraformaldehyde in 0.1 M phosphate buffer (PB) with a pH 7.4, then washed in PB, cryoprotected through a graded sucrose series (5%,10%, 15%, and 20% in PB), and frozen in OCT (Sakura Finetek, Torrance, CA):20% sucrose (2:1) \[[@r22]\]. A cryostat was used to cut 18-μm sections, which were then mounted on Super-Frost glass slides (Thermo Fisher Scientific, Waltham, MA), air-dried, and stored at −80 °C.

After acclimating to room temperature, the sections were washed for 5 min in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~, 1.8 mM KH~2~PO~4~, pH 7.4), then another 5 min in PBX (PBS containing 0.5% (v/v) Triton X-100), and then incubated for 1 h in blocking solution (PBX containing 5% (v/v) normal donkey serum). The retinal sections were incubated in primary antibodies diluted in blocking solution, at room temperature overnight. The antibody against mouse mGluR6 amino acids 853--871 (KKTSTMAAPPKSENSEDAK) was generated in sheep \[[@r23]\]. Anti-PKCα antibody was used at 1:1,000 dilution (Sigma, P4334). After incubation with the primary antibody, the sections were washed with three 10-min cycles of PBX and one 10-min cycle of PBS. The sections were then incubated at room temperature for 1 h with fluorescently labeled secondary antibodies (1:1,000 in blocking solution). The secondary antibodies were Alexa Fluor 488 donkey anti-sheep and Alexa Fluor 546 donkey anti-rabbit (Invitrogen, Carlsbad, CA). The slides were then washed three times in PBX and coverslipped with Vectashield Mounting Media (Vector Laboratories, Burlingame, CA). The sections were imaged on a confocal microscope (Olympus FV1000, Center Valley, PA), using a 60X oil objective (1.45 NA). Images shown here are maximum projections of confocal stacks, after adjustment for contrast and brightness with Fluoview software.

Electroretinography
-------------------

Mice were dark-adapted overnight, anesthetized (ketamine: 80 mg/kg; xylazine: 16 mg/kg), and administered eye drops for pupil dilation (1% tropicamide; 2.5% phenylephrine HCl; 1% cyclopentolate HCl) and to anesthetize the corneal surface (1% proparacaine HCl). Needle electrodes were placed in the cheek (reference) and tail (ground). ERGs were recorded using a stainless steel electrode wetted with 1% carboxymethylcellulose.

Strobe flash stimuli were presented to the dark-adapted eye, and after a minimum of 5 min of light adaptation using background illumination at 20 cd/m^2^. Stimuli ranged from −3.6 to 2.1 log cd s/m^2^. Responses were amplified (0.03--1,000 Hz), averaged, and stored using an LKC (Gaithersburg, MD) UTAS E-3000 signal averaging system.

The amplitude of the dark-adapted ERG a-wave was measured from the prestimulus baseline to 8 ms after the flash onset. The amplitude of the b-wave was measured from the a-wave trough to the positive peak, or from the baseline to the positive peak for stimulus conditions that did not evoke an a-wave. The amplitude of the light-adapted ERG b-wave was measured from the initial negative trough to 40 ms after the flash onset.

The stimulus-response function of the dark-adapted b-wave was fitted with a hyperbolic equation of the following form \[[@r24]\]:
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In this equation, *R* is the b-wave amplitude, *R~max~* is the maximum b-wave amplitude, *L* is the flash luminance (log cd s/m^2^), *n* is a dimensionless slope parameter, and *K* is the flash energy that elicits an amplitude of half *R~max~* (half-saturation coefficient). This model yielded values for two parameters (i.e., *R~max~* and *K*). *Grm6^nob3/nob8^* and *Grm6^nob8^* mice were tested at postnatal day (P) 15, P21, and P28. The *Grm6^nob8^* mice were also tested at 9, 28, 48, and 68 weeks of age.

In vivo retinal imaging
-----------------------

Procedures for animal preparation, imaging, and recovery have been published \[[@r25],[@r26]\]. Briefly, a Bioptigen (Durham, NC) model SDOIS SD-OCT system was used for spectral domain optical coherence tomography (SD-OCT) imaging. B-scans were made through the optic nerve head at 1,000 A-scans/B-scan × 30 frames. B-scan images had dimensions of 0.4 mm (depth) by approximately 1.6 mm (width), and were exported to ImageJ, coregistered, and averaged using StackReg/TurboReg/Plugins \[[@r27]\]. Using SD-OCT images taken across the horizontal and vertical meridians from each mouse, the thickness of the inner nuclear layer (INL) was measured at a point midway between the optic nerve head and the edge of the image. The *Grm6^nob8^* mice were imaged at three ages (11, 39, and 57 weeks old).

Results
=======

Impact of reduced levels of mutant mGluR6
-----------------------------------------

The *Grm6^nob8^* retina is characterized by a selective reduction in the amplitude of the ERG b-wave and mislocalization of mGluR6 to the cell body of DBCs, as opposed to its normal restriction to the DBC dendritic tips \[[@r14]\]. To determine whether either of these abnormalities might be ameliorated by reducing the total amount of mutant mGluR6 protein, we compared these features in *Grm6^nob8^* homozygotes and *Grm6^nob3/nob8^* compound heterozygotes. These mice differ with respect to the total content of mGluR6, with retinas of *Grm6^nob3/nob8^* compound heterozygotes having approximately half compared to *Grm6^nob8^* homozygotes ([Figure 1A,B](#f1){ref-type="fig"}).

![Western blotting analysis of mGluR6 content in WT and *Grm6* mutants. **A**: Western blots for mGluR6 in wild-type (WT; lanes 1 and 2), *Grm6^nob8^* homozygotes (lanes 3 and 4), *Grm6^nob3/nob8^* compound heterozygotes (lanes 5 and 7), and a *Grm6^nob3^* homozygote (lane 6). **B**: Densitometric analysis of western blots, demonstrating that mGluR6 levels are dramatically reduced in all *Grm6* mutants, and that mGlur6 levels of *Grm6^nob3/nob8^* compound heterozygotes are reduced to approximately half of the levels seen in *Grm6^nob8^* homozygotes. Each bar indicates average +/− standard error of three samples. Statistically significant differences were detected between groups with Aspin-Welch's *t* test (\*p\<0.05, \*\*p\<0.01).](mv-v25-890-f1){#f1}

The mGluR6 expression was observed only in the DBC dendritic tips of the control mice ([Figure 2A,C](#f2){ref-type="fig"}), with no overlap with PKCα labeling in the DBC soma ([Figure 2B,C](#f2){ref-type="fig"}). In the *Grm6^nob8^* homozygotes, mGluR6 expression was reduced ([Figure 1D](#f1){ref-type="fig"}) and colocalized with PKCα in DBC soma ([Figure 2E,F](#f2){ref-type="fig"}). The distribution of mGluR6 in the *Grm6^nob3/nob8^* compound heterozygotes ([Figure 2G--I](#f2){ref-type="fig"}) matched that of the *Grm6^nob8^* homozygotes with extensive expression throughout the cell body and limited expression at the DBC dendritic tips. This result indicates that the mislocalization of mGluR6 was not corrected when only a single *Grm6^nob8^* allele was expressed, resulting in a reduction in the total amount of mutant mGluR6 ([Figure 1A,B](#f1){ref-type="fig"}).

![Cellular localization of mGluR6 and PKCα in retinas from the mice at 4 weeks of age. In contrast to the control retinas (**A**--**C**), the *Grm6^nob3/nob8^* retinas (**G**--**I**) exhibited a similar mGluR6 distribution pattern to that of the *Grm6^nob8^* retinas (**D**--**F**). Scale bars: 10 μm. OPL, outer plexiform layer.](mv-v25-890-f2){#f2}

When the *Grm6^nob3/nob8^* compound heterozygotes were examined with ERG, the results complemented those obtained with immunohistochemistry. In [Figure 3A](#f3){ref-type="fig"}, the ERG phenotypes of representative *Grm6^nob8^* and *Grm6^nob3/nob8^* mice are compared at P28, along with a reference control mouse at the same age. The dark-adapted a-waves in the *Grm6^nob3/nob8^* mice showed amplitudes and kinetics that were comparable to those of the *Grm6^nob8^* mice ([Figure 3A,B](#f3){ref-type="fig"}; p\>0.05). In contrast, the dark-adapted b-waves of the *Grm6^nob3/nob8^* mice were statistically significantly smaller than those in the *Grm6^nob8^* mice ([Figure 3A,B](#f3){ref-type="fig"}; p\<0.01), consistent with these mice expressing a single *Grm6^nob8^* allele. The small b-wave and oscillatory potentials present in the dark-adapted ERGs of the *Grm6^nob3/nob8^* mice are, however, clearly larger than those reported for the *Grm6^nob3^* homozygotes \[[@r12],[@r13]\]. There was no statistically significant difference in the amplitude of the light-adapted b-waves obtained from the *Grm6^nob8^* and *Grm6^nob3/nob8^* mice ([Figure 3C,D](#f3){ref-type="fig"}; p\>0.05).

![Comparison of ERGs from control, *Grm6^nob8^*, and *Grm6^nob3/nob8^* mice at P28. ERGs were elicited under dark-adapted (**A**) or light-adapted (**C**) condition. Flash strength (in log cd s/m^2^) is indicated on the left of each set of waveforms. **B**: Amplitude of dark-adapted a- and b-waves plotted as a function of flash luminance. **D**: Amplitude of light-adapted b-wave plotted as a function of flash luminance. In **B** and **D**, each plot indicates average +/− standard error of four (*Grm6^nob8^*) or six (*Grm6^nob3/nob8^*) mice. Repeated-measures ANOVA (ANOVA) was used to compare response functions. Compared to the *Grm6^nob8^* mice, the *Grm6^nob3/nob8^* mice showed comparable a-wave (p\>0.05) and reduced b-wave (\*p\<0.01) under the dark-adapted condition. The difference in the amplitude of the light-adapted b-wave was not statistically significant between groups (p\>0.05).](mv-v25-890-f3){#f3}

We also used ERG to examine mice at younger ages. [Figure 4](#f4){ref-type="fig"} presents representative ERGs obtained from *Grm6^nob8^* homozygotes (black) and *Grm6^nob3/nob8^* compound heterozygotes (red) at P15 and P21. At P21, a clear albeit reduced b-wave was present in all animals, with a greater reduction observed in the *Grm6^nob3/nob8^* compound heterozygotes compared to the *Grm6^nob8^* homozygotes. We did not detect a b-wave in either the *Grm6^nob3/nob8^* compound heterozygotes or the *Grm6^nob8^* homozygotes at P15, an age when the retina is still developing, and the ERG has not taken on an adult configuration \[[@r28]\].

![Comparison of dark-adapted ERG from *Grm6^nob8^* and *Grm6^nob3/nob8^* mice at P15 and P21. Flash strength (in log cd s/m^2^) is indicated on the left of each set of waveforms. At P15, no obvious b-wave was detected either from the *Grm6^nob8^* or the *Grm6^nob3/nob8^* mice. At P21, a clear albeit reduced b-wave is present in all animals, with a greater reduction observed in the *Grm6^nob3/nob8^* mice when compared to the *Grm6^nob8^* mice.](mv-v25-890-f4){#f4}

Changes in the older *Grm6^nob8^* retina
----------------------------------------

To examine whether the *Grm6^nob8^* phenotype might change with age, we examined mice at different ages. The overall waveforms of the ERGs obtained from 4- and 68-week old *Grm6^nob8^* mice were in good general agreement for dark- and light-adapted conditions ([Figure 5A,C](#f5){ref-type="fig"}). [Figures 5B,D](#f5){ref-type="fig"} present summary luminance-response functions for ERG components obtained from mice at 4, 9, 28, 48, and 68 weeks of age. These data are not indicative of a progressive age-related change in the ERG amplitude. We further analyzed the dark-adapted b-wave luminance-response functions using the Naka-Rushton equation, which derives two parameters: the maximum response (*R~max~*) and the sensitivity (*K*). The *R~max~* values appeared to decrease slightly with age, which is in good agreement with a previous report showing a slight decrease in the ERG amplitude with age in wild-type mice \[[@r29]\]. When the values seen at the youngest age (4 weeks old) were compared to the later time points, the difference was not statistically significant ([Figure 5E](#f5){ref-type="fig"}; p\>0.05). The sensitivity parameter *K* trended upward with age ([Figure 5F](#f5){ref-type="fig"}). When the *K* values of the 4-week-old mice were compared to those obtained from the two oldest ages, there was no statistically significant difference (p\>0.05). Together, these results indicate that retinal dysfunction in *Grm6^nob8^* mice is not progressive.

![Longitudinal evaluation of ERG phenotype in adult *Grm6^nob8^* mice. Comparison of dark- (**A**) and light-adapted (**C**) electroretinograms (ERGs) from young adult (4 weeks) and old (68 weeks) *Grm6^nob8^* mice. Flash strength (in log cd s/m^2^) is indicated on the left of each set of waveforms. **B**: Amplitude of dark-adapted a- and b-waves plotted as a function of flash luminance. **D**: Amplitude of the light-adapted b-wave plotted as a function of flash luminance. In **B** and **D**, each plot indicates average +/− standard error of four to five mice. Time course change in the maximum response (*R~max~*, **E**) and sensitivity (*K*, **F**) parameters of the dark-adapted b-wave amplitude. When the *R~max~* and *K* values of 4-week old mice were compared to those of older mice, the differences were not statistically significant (Aspin-Welch's *t* test, p\>0.05).](mv-v25-890-f5){#f5}

In [Figure 6A](#f6){ref-type="fig"}, the SD-OCT images taken across the horizontal meridian from *Grm6^nob8^* mice at 11, 39, and 57 weeks of age are compared. At each age examined, a clear INL, housing bipolar cell nuclei, was seen in the *Grm6^nob8^* mice. Although the INL thickness in the mice at 39 weeks or older was thinner than that at 11 weeks old ([Figure 6B](#f6){ref-type="fig"}), the laminar structure of the retina was maintained until the oldest age was tested.

![Longitudinal evaluation of SD-OCT image in adult *Grm6^nob8^* mice. **A**: The upper image is a representative image taken across the horizontal meridian from a *Grm6^nob8^* mouse at 57 weeks of age showing the well-defined laminar structure of the retina. Lower images were taken from *Grm6^nob8^* mice at the ages indicated. ELM, external limiting membrane; EZ, ellipsoid zone; INL, inner nuclear layer; IPL, inner plexiform layer; ONL, outer nuclear layer; OPL, outer plexiform layer; RPE, retinal pigment epithelium. **B**: Thickness of the INL at 11, 39, and 57 weeks of age. The INL was thicker at 11 weeks of age, compared to the older ages (Aspin-Welch's *t* test; \*p\<0.05, \*\*p\<0.01). Each plot indicates average +/− standard error of four (11 weeks old) or three (39 and 57 weeks old) mice.](mv-v25-890-f6){#f6}

Discussion
==========

Unlike other *Grm6* mouse models, where the retina lacks mGluR6 protein due to a null mutation \[[@r10]-[@r13]\], mGluR6 is detected in the *Grm6^nob8^* retina \[[@r14]\]. The distribution of the mutant protein differs from that of the wild type. First, mGluR6 is clearly seen in the DBC soma. Second, the amount of protein that is successfully trafficked to the DBC dendritic tips is reduced. In agreement with mislocalized mGluR6, the ERG b-wave is reduced in *Grm6^nob8^* mice, and retinal ganglion cell function is also impaired \[[@r14]\]. The mislocalization of mutant mGluR6 could be related to abnormal protein folding and trafficking mechanisms, secondary to the abnormal glycosylation of mGluR6 noted in the *Grm6^nob8^* retina \[[@r14]\].

We hypothesized that reducing the total amount of mutant mGluR6 protein might improve the amount of mGluR6 that is successfully delivered to the DBC dendritic tips. Previous studies demonstrated that a single copy of WT *Grm6* is sufficient to support normal DBC function \[[@r30]\], and therapeutic strategies (such as hammerhead ribozymes) exist to reduce gene expression in the retina \[[@r31]-[@r33]\]. This has relevance for patients with cCSNB, as some are known to carry mutations that lie near the *nob8* locus \[[@r20]\], although we do not yet know if they also cause mislocalization. To test this hypothesis, we generated *Grm6^nob3/nob8^* compound heterozygotes, which express a single *Grm6^nob8^* allele; *Grm6^nob3^* is a null mutation \[[@r12]\]. In contrast to the possibility that mGluR6 protein and/or DBC function might be improved in the *Grm6^nob3/nob8^* retina compared to the *Grm6^nob8^* retina, we observed neither normalization of mGluR6 localization nor an improved ERG b-wave. Instead, the b-wave was reduced in compound heterozygotes. These results indicate that simply reducing mutant mGluR6 protein will not provide a therapeutic avenue, and instead, suggest that some other means of improving mGluR6 trafficking to the DBC dendritic tips is needed.

A large number of mouse mutants have been reported where the ERG b-wave is reduced or abolished \[[@r34]\]. In general, the b-wave is abolished in mice with mutations in members of the DBC signaling cascade, including *Nyx* \[[@r35],[@r36]\], *Trpm1* \[[@r30],[@r37]-[@r39]\], *Gpr179* \[[@r40]\], *Lrit3* \[[@r41]-[@r43]\], *Gnb3* \[[@r44]\], *Gnb5* \[[@r45]\], *Gna01* \[[@r46]\], and *Grm6* \[[@r10]-[@r12]\], or in mice that lack DBCs \[[@r47]\]. In comparison, the b-wave is reduced but not abolished in mice with mutations in proteins that are involved in multiple other systems, including the control of glutamate release from photoreceptor terminals (*Cacna1f* \[[@r48]-[@r50]\], *Cacna2d4* \[[@r51],[@r52]\], and *Cabp4* \[[@r53]\]), the development of retinal vasculature (*Fzd4* \[[@r54]\], *norrin* \[[@r55],[@r56]\], and *Lrp5* \[[@r57]\]), or the dystroglycan complex (*pikachurin* \[[@r58]\], *POMGnT1* \[[@r59]\], and *Large* \[[@r60]-[@r62]\]). Based on the premise that the b-wave is abolished in mice with mutations of the DBC signaling process, we anticipated that the *nob8* mice would involve one of the processes that reduces but does not abolish DBC function \[[@r63]\], and were surprised when the mutation in *Grm6* was identified \[[@r14]\]. The *Grm6^nob8^* mouse is the first mouse mutant to retain a b-wave in the presence of a mutation in a component of the DBC signaling cascade, and raises the possibility that similar variation may occur in human patients with CSNB, who are currently classified into complete and incomplete forms based in part on the absence of the b-wave in complete CSNB and on the presence of a reduced but not abolished b-wave in patients with incomplete CSNB \[[@r64]\]. Human patients expressing mutations in the glutamate ligand binding domain of GRM6, near the Met66 residue, have been reported \[[@r20]\]. It would be of interest to determine if they retained a measurable ERG b-wave compared to patients with CSNB with other *Grm6* mutations.

Protein-misfolding diseases, such as Alzheimer disease and Huntington\'s disease, involve the accumulation of misfolded proteins with abnormal conformation in neurons \[[@r65]\]. Furthermore, it has been reported that patients with complete CSNB harboring a *GRM6* mutation showed reduced inner retinal thickness with OCT imaging \[[@r66]\]. This motivated us to investigate whether long-term accumulation of mutant mGluR6 protein in DBC cell bodies might impact the inner retina of *Grm6^nob8^* mice. ERG and SD-OCT analyses of *Grm6^nob8^* mice at multiple ages indicate that rod DBC function is maintained at a reduced but stable level up to 68 weeks of age, and that a clear laminar structure of the retina is maintained up to 57 weeks old, with only a slight thinning of the INL. The absence of major age-related changes in the ERG b-wave or in the overall retinal structure indicated that DBCs tolerate the presence of mislocalized mutant p.Met66Leu mGluR6.
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